Clinical Trial Update: Once-daily Highly Active Antiretroviral Treatment Regimen Administration in HIV-1 Infected Children in Burkina Faso (ANRS 12103 BURKINAME) [Phase 2]

View source ↗

Summary

This update describes a Phase 2 clinical trial (ANRS 12103 BURKINAME) evaluating a once-daily highly active antiretroviral regimen in HIV-1 infected children in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis | Conditions: HIV Infections, AIDS | Phase 2 | Status: COMPLETED